Individuals are increasingly using substances that are marketed as natural supplements or alternatives to conventional medications. Kava (Piper methysticum) is one of several emerging substances, alongside kratom, tianeptine, and phenibut, that may contribute to intoxication, dependence, withdrawal, or unexpected clinical presentations. These exposures may not be disclosed during routine history-taking and are not typically detected by standard drug testing.
Kava is a psychoactive plant traditionally consumed for its calming and sedative effects. Today, it is widely available in beverages, capsules, gummies, concentrated shots, and combination products that may also contain substances such as kratom.
Patients may use kava for:

Reported effects of kava exposure may include:
Although uncommon, hepatotoxicity has also been reported. Chronic or heavy use may result in dependence and withdrawal, including presentations involving agitation, hallucinations, or delirium.
Kava is frequently used alongside:
The combined use of kava and kratom is an emerging concern. In 2025, kratom was involved in approximately 30% of kava-related poison center reports. Awareness of these patterns may help provide additional context when evaluating adverse effects, withdrawal symptoms, or treatment response.

Patients may not view kava as a drug or substance of concern and therefore may not report use unless specifically asked.
Consider definitive kava testing when:
Because kava is not typically identified through routine medication histories or conventional drug testing, definitive testing may provide valuable insight into patient substance exposure.
Definitive laboratory testing for kava is available through:
The Aegis Clinical Team is available for questions regarding interpretation, testing strategy, or complex substance use presentations.